The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow sales in the years ahead.

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pfizer Inc. agreed to pay over $59,746,277 to resolve allegations that its wholly owned subsidiary, Biohaven Pharmaceutical Holding Company Ltd., violated the Anti-Kickback Statute (AKS) and False ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more earnings today and an in-depth report ...

and Pfizer CEO Albert Bourla explained his big bet on finding a solution to cancer. If you're not yet a subscriber, sign up here for this newsletter. Much of Global Wall Street focused this week ...